# US 2026/0221223 A1 · Platforms, systems, and methods for using artificial intelligence for cell optimization

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0221223 A1
- Document ID: US20260221223A1
- Status: Published application
- Kind: A1
- Application number: 19/414,916
- Filed: 2025-12-10
- Published: 2026-07-30
- Earliest claimed: 2024-06-03
- Applicants: X Development LLC
- Inventors: John Ata Bachman; Laura Barker; Relly Brandman; Federico Vaggi; Nicholas Ruggero; Carl Hans Albach; Chiam Yu Ng; Jeffrey David Orth; Lin Wang
- Web page: https://patentgrep.com/patent/US20260221223A1

## CPC

- G06N 7/01: Probabilistic graphical models, e.g. probabilistic networks
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- C12M 29/00: {Means for introduction, extraction or recirculation of materials, e.g. pumps (pumps per se F04B)}
- C12M 41/48: {Automatic or computerized control (automatic analysis G01N35/00)}
- G01N 30/8651: {Recording, data aquisition, archiving and storage}
- G01N 30/8693: {Models, e.g. prediction of retention times, method development and validation}
- G06F 11/3608: {using formal methods, e.g. model checking, abstract interpretation (theorem proving G06N5/013)}
- G06F 11/3692: {for test results analysis}
- G06F 30/27: using machine learning, e.g. artificial intelligence, neural networks, support vector machines [SVM] or training a model
- G06N 3/044: Recurrent networks, e.g. Hopfield networks
- G06N 3/0442: characterised by memory or gating, e.g. long short-term memory [LSTM] or gated recurrent units [GRU]
- G06N 3/045: Combinations of networks
- G06N 3/0455: Auto-encoder networks; Encoder-decoder networks
- G06N 3/0475: Generative networks
- G06N 3/08: Learning methods
- G06N 3/088: Non-supervised learning, e.g. competitive learning
- G06N 3/091: Active learning
- G06N 5/01: Dynamic search techniques; Heuristics; Dynamic trees; Branch-and-bound
- G06N 20/00: Machine learning
- G16B 5/00: ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 20/50: Mutagenesis
- G16B 25/10: Gene or protein expression profiling; Expression-ratio estimation or normalisation
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B 35/20: Screening of libraries
- G16B 40/20: Supervised data analysis
- G16B 40/30: Unsupervised data analysis
- G16C 20/10: Analysis or design of chemical reactions, syntheses or processes
- G16C 20/70: Machine learning, data mining or chemometrics
- G06N 20/10: using kernel methods, e.g. support vector machines [SVM]
- G16B 5/20: Probabilistic models
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G06F: ELECTRIC DIGITAL DATA PROCESSING (computer systems based on specific computational models G06N)
- G16C: COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE

## Abstract

A system may include a set of data integration facilities for integrating content of at least one publication data set relating to the biological strain and at least one proprietary data set including a set of parameters of a synthetic biological process in which the biological strain produces a functional output, wherein the output of data integration facilities is configured as an input to a set of artificial intelligence (AI)-based learning models. The system may include at least one member of the set of AI-based learning models that is configured to generate a set of recommendations wherein the set of recommendations relates to modifications to a set of genes of the biological strain such that the set of recommendations enhance production of the functional output by the biological strain.

## Claims

### Claim 1

A platform for generating a set of recommendations for modifications to a set of genes of a biological strain for production of a functional output, comprising:
a set of data integration facilities for integrating content of at least one publication dataset relating to the biological strain and at least one proprietary data set including a set of parameters of a synthetic biological process for the production of the functional output by the biological strain, wherein the output of data integration facilities is configured as an input to a set of artificial intelligence (AI)-based learning models; and
at least one member of the set of AI-based learning models that is configured to generate the set of recommendations, wherein the set of recommendations relates to modifications to the set of genes of the biological strain, such that the set of recommendations enhances the production of the functional output by the biological strain.

### Claim 2 (depends on 1)

The platform of claim 1, wherein the set of AI-based learning models includes at least one of a transformer model, a convolutional neural network, a deep learning model, a supervised model, a semi-supervised model, an unsupervised model, a reinforcement model, a long short-term memory (LSTM) model, a multi-layer perceptron, lin-log model, a large language model, a large protein model, or a protein language model.

### Claim 3 (depends on 1)

The platform of claim 1, wherein the at least one publication dataset includes at least one of: gene function description datasets, datasets from metabolic pathway databases, comparative genomics datasets, omics datasets, functional assay datasets, experiment result datasets, bioinformatics analyses datasets, regulatory study datasets, enzyme characterization datasets, case study datasets, or patent literature.

### Claim 4 (depends on 1)

The platform of claim 1, wherein the at least one proprietary dataset includes at least one of genetic parameters, metabolic parameters, growth and physiological parameters, environmental and culture conditions, process parameters, functional output parameters, regulatory and control parameters, phenotypic parameters, omics parameters, scale-up parameters, or energy consumption parameters.

### Claim 5 (depends on 1)

The platform of claim 1, wherein the set of recommendations relates to at least one of knockout mutations, overexpression of target genes, activation of specific genes, insertion of specific genes, gene knockdowns, site-directed mutagenesis, promoter engineering, codon optimization, gene fusion, allele replacement, creation of synthetic gene circuits, introduction of regulatory elements, or application of advanced genome editing technologies.

### Claim 6 (depends on 1)

The platform of claim 1, wherein the functional output includes at least one of fuel applications and solutions, industrial applications and solutions, consumer product applications and solutions, pharmaceutical applications and solutions, or medical applications and solutions.

### Claim 7 (depends on 1)

The platform of claim 1, further comprising a simulation engine, the simulation engine configured to:
generate a plurality of simulated synthetic biological process scenarios in which the biological strain produces the functional output, wherein each process scenario has a different set of modifications to the set of genes;
execute simulations for the plurality of simulated process scenarios; and
generate simulation data based on the executed simulations;
wherein the set of AI-based learning models is further configured to:
receive the simulation data as additional input; and
generate the set of recommendations based at least in part on the simulation data.

### Claim 8 (depends on 7)

The platform of claim 7, wherein the simulations involve a set of digital twins representing at least one of a biological strain digital twin, a gene digital twin, a genome digital twin, a pathway digital twin, a bioreactor digital twin, a protein digital twin, a metabolite digital twin, or an enzyme digital twin.

### Claim 9

A method, comprising:
integrating, by a set of data integration facilities, content of at least one publication data set relating to a biological strain and at least one proprietary data set including a set of parameters of a synthetic biological process for production of a functional output by the biological strain;
providing the integrated content as input to a set of artificial intelligence (AI)-based learning models; and
generating, by at least one member of the set of AI-based learning models, a set of recommendations wherein the set of recommendations relates to modifications to a set of genes of the biological strain, such that the set of recommendations enhances the production of the functional output by the biological strain.

### Claim 10 (depends on 9)

The method of claim 9, wherein the set of AI-based learning models includes at least one of a transformer model, a convolutional neural network, a deep learning model, a supervised model, a semi-supervised model, an unsupervised model, a reinforcement model, a long short-term memory (LSTM) model, a multi-layer perceptron, lin-log model, a large language model, a large protein model, or a protein language model.

### Claim 11 (depends on 9)

The method of claim 9, wherein the at least one publication data set includes at least one of: gene function description datasets, datasets from metabolic pathway databases, comparative genomics datasets, omics datasets, functional assay datasets, experiment result datasets, bioinformatics analyses datasets, regulatory study datasets, enzyme characterization datasets, case study datasets, or patent literature.

### Claim 12 (depends on 9)

The method of claim 9, wherein the at least one proprietary data set includes at least one of genetic parameters, metabolic parameters, growth and physiological parameters, environmental and culture conditions, process parameters, functional output parameters, regulatory and control parameters, phenotypic parameters, omics parameters, scale-up parameters, or energy consumption parameters.

### Claim 13 (depends on 9)

The method of claim 9, wherein the set of recommendations relates to at least one of knockout mutations, overexpression of target genes, activation of specific genes, insertion of specific genes, gene knockdowns, site-directed mutagenesis, promoter engineering, codon optimization, gene fusion, allele replacement, creation of synthetic gene circuits, introduction of regulatory elements, or application of advanced genome editing technologies.

### Claim 14 (depends on 9)

The method of claim 9, wherein the functional output includes at least one of fuel applications and solutions, industrial applications and solutions, consumer product applications and solutions, pharmaceutical applications and solutions, or medical applications and solutions.

### Claim 15 (depends on 9)

The method of claim 9, further comprising:
generating, by a simulation engine, a plurality of simulated synthetic biological process scenarios in which the biological strain produces the functional output, wherein each process scenario has a different set of modifications to the set of genes;
executing simulations for the plurality of simulated process scenarios;
generating simulation data based on the executed simulations;
receiving the simulation data as additional input to the set of AI-based learning models; and
generating the set of recommendations based at least in part on the simulation data.

### Claim 16 (depends on 15)

The method of claim 15, wherein the simulations involve a set of digital twins representing at least one of a biological strain digital twin, a gene digital twin, a genome digital twin, a pathway digital twin, a bioreactor digital twin, a protein digital twin, a metabolite digital twin, or an enzyme digital twin.

### Claim 17

(canceled)

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20

(canceled)
